Moreover, in PDX models of hormone-independent breast cancer with ERα mutations, treatment with ARV-471 in a dose of 10 mg/kg completely inhibited tumor growth accompanied with significantly reduced mutant ER levels. The gene discussed is ESR1; the disease is breast cancer.